Article info

PDF

Research paper
Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial

Authors

  1. Correspondence to Dr Satoshi Kuwabara, Department of Neurology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan; kuwabara-s{at}faculty.chiba-u.jp
View Full Text

Citation

Kuwabara S, Mori M, Misawa S on behalf of the Glovenin-I CIDP Study Group, et al
Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial

Publication history

  • Received 13 May 2017
  • Revised 14 June 2017
  • Accepted 19 June 2017
  • Published in print 1 October 2017.
  • Published online 11 September 2017.
  • Published first 2 August 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.